CASP Module 21: Introduction to Clinical Research & Emerging Therapies
CASP Certification Program

Module 21: Clinical Research & Emerging Therapies

From Dispensing Excellence to Advancing the Frontier of Medicine.

Bridging Practice with Discovery: The Pharmacist’s Role in the Future of Therapy

Throughout this program, we have focused on mastering the complexities of current specialty pharmacy practice – navigating access barriers, optimizing complex regimens, managing high-touch patient care, and leveraging sophisticated technology. You have honed the skills needed to excel in today’s demanding environment.

This module marks a significant pivot. We now look beyond established therapies and operational workflows to explore the dynamic and rapidly evolving landscape where specialty pharmacy intersects with clinical research and the development of truly novel treatments. The skills you’ve acquired in managing complex patients, handling high-cost biologics, and meticulously documenting clinical data position you uniquely at the forefront of medical innovation.

We will delve into the critical role specialty pharmacies play in supporting clinical trials, managing investigational drugs under stringent FDA regulations, and contributing vital real-world data to shape our understanding of drug performance. Furthermore, we will venture into the operational intricacies of the next generation of therapeutics – gene, cell, and mRNA therapies – demanding entirely new levels of logistical precision and clinical oversight. This module elevates your perspective from executing established protocols to actively participating in the discovery and delivery of tomorrow’s cures.

Navigating the Research & Innovation Landscape

This module examines the expanding responsibilities and unique capabilities of specialty pharmacies in the realm of clinical research and groundbreaking therapies.

21.1 Role of Specialty Pharmacy in Clinical Trials

Exploring how SPs support patient recruitment, drug distribution, adherence monitoring, data collection, and regulatory compliance within Phase II-IV clinical trials.

21.2 Investigational Drug Services & IND Compliance

A deep dive into the specialized operations for handling investigational drugs, including storage, dispensing, accountability logs, blinding protocols, and adherence to Investigational New Drug (IND) regulations.

21.3 Pharmacovigilance and Signal Detection

Understanding the SP’s critical role in post-marketing surveillance, identifying, documenting, and reporting adverse drug events (ADEs), and contributing to early signal detection for safety issues.

21.4 Data Contribution to Real-World Evidence Studies

Examining how aggregated, de-identified specialty pharmacy data (dispensing, clinical outcomes) is leveraged for Real-World Evidence (RWE) generation, informing payer decisions and post-market research.

21.5 Gene, Cell, and mRNA Therapy Operations

Exploring the ultra-complex logistical, storage (cryogenic), handling, and patient management requirements for delivering cutting-edge gene, cell (e.g., CAR-T), and mRNA therapies.